Data as of Sep 29, 2026 · Based on 1,039 AI responses · See how Parse measures this
Makya is the first generative AI platform designed by chemists for chemists to streamline drug discovery by generating diverse, novel, medchem-like molecules that rapidly converge toward drug candidates, with synthesis constraints and target product profile constraints baked in from the start. As a SaaS with an easy-to-use interface, Makya leverages learned organic chemistry at scale to explore vast chemical space, supports 3D ligand-based and structure-based design, SAR/ADMET modeling, multi-parameter optimization, and includes built-in retrosynthesis via Spaya to ensure synthetic feasibility by design. Makya 2.0 introduces enhanced data analysis and visualization, better ligand design models, advanced filtering and 3D interaction scoring, and API connectivity to external scoring functions to accelerate collaboration between medicinal and computational chemists.
0%No change
of AI answers about Iktos Makya and its rivals. Week of Sep 21
“Iktos Makya: A distinct generative AI software tailored sharply for medicinal and synthetic chemistry.”
“Iktos Makya : Focuses on chemistry-aware generative design, creating molecules step-by-step using known reactions to ensure synthetic feasibility while improving potency.”
“Iktos Makya: A chemistry-aware AI platform designed for de novo design”
AI mentioned Iktos Makya in 0% of answers about Iktos Makya and its rivals in the week of Sep 21.
Iktos Makya is a product of Iktos.
